New Skin-Tightening device tested on all skin types, including Weight-Loss drug users

NCT ID NCT07224880

First seen Nov 05, 2025 · Last updated Jun 13, 2026 · Updated 34 times

Summary

This study is testing a device called Ellacor that uses tiny needles to remove small pieces of skin, aiming to reduce wrinkles and tighten loose skin on the face and belly. It includes 10 adults aged 30-65 with moderate to severe wrinkles and skin laxity, and also looks at how the device works in people taking GLP-1 medications (like Ozempic) for weight loss. The main goal is to see if the treatment is safe and effective across different skin types, with follow-up visits over 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP1 AGONIST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tri Valley Plastic Surgery

    RECRUITING

    Dublin, California, 94568, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.